Page 337 - ASHG 2013 Program Guide

318  
CMEs and CEUs
Continuing Education Unit Credits (CEUs) for Genetic Counselors
ASHG has been approved for up to
27.25
CEUs (
27
contact hours
)
for genetic coun-
selors through the National Society of Genetic Counselors (NSGC). NSGC is approved
as an authorized provider of continuing education and training by the International
Association for Continuing Education and Training (IACET).
Procedures:
There is a
non-refundable
$40 fee payable during the ­registration
­
process. Registrants MUST apply for credits via the online submission system­
after
the meeting. The submission site will open on Saturday, October 26, 2013.
The ­deadline
to request credits is Monday, December 3, 2013
.
No submissions
will be taken after this deadline. You will need your registration ID to complete the
CEU ­application. Those who registered in advance received an e-mail with instruc-
tions and a copy of the tracking form. For your convenience, tracking forms will also
be ­available in the ASHG Meeting Office, Room 254.
Genetic counselors and nurses should apply for CEUs. The American Board of
­
Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes
of ­certification and recertification.
ASHG 2013 Learning Objectives
All attendees obtaining CME credits will be able to apply the newly acquired ­knowledge
andmethods in the evaluation, diagnosis, intervention, treatment and follow-up of ­patients
with a variety of disorders. At the completion of the meeting, participants will be able
to: (1) recognize gaps in knowledge of facts and new methods in genetics; (2) demon-
strate ways that the new information and its context may be applied in their own prac-
tices; (3) better interpret results of complex genetic tests and recognize instances of most
­
appropriate use; and (4) understand in detail the benefits and potential harms of using
the newest genetic technologies. The 2013 ASHG Annual Meeting will help attendees to:
Identify and fill gaps in knowledge in human genetics in areas of statistical
analysis, full genome sequencing, next-generation sequencing, genetic
neurodegenerative and other disorders, and epigenetics.
Explain the value and use of newest technological methods in full genome
sequencing in diagnosis of disorders and family studies.
Provide context from discussions on the benefits and harms of returning
results of full genome sequencing to patients.
Set principles for the provision of results and their interpretation in full genome
sequencing and the diagnosis of genetic risks and explain how genome
sequencing may be useful in an undiagnosed patient.
Accrue guidelines for the successful counseling of patients receiving complex
genetic results.
Present the newest results of gene therapy trials so clinicians may enroll
patients or apply therapies to appropriate patents.
Identify and explain the newest non-invasive pre-natal diagnostic methods.
Integrate results of genomic testing into electronic health records and other
methods to store information.